Northern Trust’s TuHURA Biosciences HURA Stock Holding History

Northern Trust’s Portfolio HURA Stock Details HURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.79M	Buy	1,621,042 +1,322,855	+444%	+$3.08M	﹤0.01%	2770
2026 Q1	$534K	Buy	298,187 +106,551	+56%	+$131K	﹤0.01%	3595
2025 Q4	$145K	Buy	191,636 +4,820	+3%	+$9.22K	﹤0.01%	4068
2025 Q3	$463K	Sell	186,816 -14,398	-7%	-$37.9K	﹤0.01%	3673
2025 Q2	$449K	Buy	201,214 +143,966	+251%	+$486K	﹤0.01%	3676
2025 Q1	$185K	Hold	57,248	–	–	﹤0.01%	3969
2024 Q4	$234K	Buy	+57,248	New	+$304K	﹤0.01%	3928
2022 Q4	–	Sell	-25	Closed	-$5K	–	4716
2022 Q3	$5K	Hold	25	–	–	﹤0.01%	4679
2022 Q2	$12K	Hold	25	–	–	﹤0.01%	4682
2022 Q1	$18K	Hold	25	–	–	﹤0.01%	4678
2021 Q4	$23K	Hold	25	–	–	﹤0.01%	4700
2021 Q3	$38K	Hold	25	–	–	﹤0.01%	4568
2021 Q2	$100K	Hold	25	–	–	﹤0.01%	4361
2021 Q1	$77K	Buy	25 +12	+92%	+$40.8K	﹤0.01%	4329
2020 Q4	$28K	Buy	13 +6	+86%	+$15K	﹤0.01%	4297
2020 Q3	$17K	Hold	7	–	–	﹤0.01%	4232
2020 Q2	$9K	Buy	+7	New	+$8.96K	﹤0.01%	4223

Other funds holding HURA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

AWM

Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return

Northern Trust's HURA Position: Q2 2026 in Review

Northern Trust increased its TuHURA Biosciences (HURA) stake by 444% in Q2 2026, buying an estimated $3.08M and bringing the position to 1,621,042 shares worth $3.79M. The position accounts for ﹤0.01% of the portfolio, ranked #2770.

Northern Trust first reported a position in HURA in Q2 2020 and has held it in 17 quarters since. 90 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

Northern Trust held 1,621,042 shares of TuHURA Biosciences worth $3.79M as of Q2 2026.
Northern Trust bought 1,322,855 TuHURA Biosciences shares in Q2 2026, an estimated $3.08M.
TuHURA Biosciences made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2770 holding.
Northern Trust first reported a position in TuHURA Biosciences in Q2 2020 and has held it in 17 quarters since.
90 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.